Find the Perfect Plan for Your Investment Journey
A
Last Price
52 Week Range
HK$5.26 - HK$9.60
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | HK$2.57B |
EV | HK$1.87B |
Shares Outstanding | 313.39M |
Beta | 0.27 |
Analyst Rating | BUY |
Analyst Target Price | HK$11.94 |
P/E 2025E | 21.42x |
P/Revenue 2025E | 3.39x |
Revenue | 20.70% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 73.40% |
Net Profit Margin 2025E | 16.01% |
ROE 2025E | 8.00% |
ROCE 2024 | 3.95% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
A
Acotec Scientific Holdings Limited
6669
Sector
Healthcare
Industry
Medical - Devices
CEO
Li, Jing
Employees
650
Website
www.acotec.cnIPO Date
2021-08-24
Headquarters
Building No. 1, 4-5th Floor, 16 North Hongda Road, Beijing Economic-Technological Dev. Area, Beijing China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved